PK Wagh, BE Peace, SE Waltz - Advances in cancer research, 2008 - Elsevier
The Ron receptor is a member of the Met family of cell surface receptor tyrosine kinases and is primarily expressed on epithelial cells and macrophages. The biological response of Ron …
SB Yan, VL Peek, R Ajamie, SG Buchanan… - Investigational new …, 2013 - Springer
The HGF/MET signaling pathway regulates a wide variety of normal cellular functions that can be subverted to support neoplasia, including cell proliferation, survival, apoptosis …
YQ Zhou, C He, YQ Chen, D Wang, MH Wang - Oncogene, 2003 - nature.com
The RON receptor tyrosine kinase is a member of the MET proto-oncogene family that has been implicated in regulating motile-invasive phenotypes in certain types of epithelial …
Colorectal cancer is the third most common malignancy in men and the second most common cancer in women. Despite the success of screening programs and the …
The product of the RON (recepteur d'origine nantais) gene belongs to the MET proto- oncogene family, a distinct subfamily of receptor tyrosine kinases. The ligand of RON was …
JM O'Toole, KE Rabenau, K Burns, D Lu… - Cancer research, 2006 - AACR
RON is a member of the c-MET receptor tyrosine kinase family. Like c-MET, RON is expressed by a variety of epithelial-derived tumors and cancer cell lines and it is thought to …
RM Thomas, K Toney, C Fenoglio-Preiser… - Cancer research, 2007 - AACR
Pancreatic cancer is an aggressive disease characterized by rapid growth and early metastasis. The recepteur d'origine nantais (RON) receptor tyrosine kinase is overexpressed …
MH Wang, W Lee, YL Luo, MT Weis… - The Journal of …, 2007 - Wiley Online Library
Aberrant expression of the RON receptor tyrosine kinase has been implicated in the pathogenesis of epithelial tumours. The aim of this study was to determine RON expression …
ER Camp, W Liu, F Fan, A Yang, R Somcio… - Annals of surgical …, 2005 - Springer
Tyrosine kinase receptors mediate many critical cellular functions that contribute to tumor progression and metastasis and thus are potential targets for molecular-based cancer …